Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnosing IBD by Evaluating Epigenetic Markers in Blood

By Gerald M. Slutzky, PhD
Posted on 07 Dec 2016
Epigenetic screening of blood samples has been proposed as a new approach to diagnosing patients with inflammatory bowel diseases (IBD).

Symptoms are similar in Crohn's disease, ulcerative colitis, and other inflammatory bowel conditions, which makes it difficult for doctors to diagnose which of the illnesses a patient has.

In an effort to develop better diagnostic tools for IBD, investigators at the University of Edinburgh (United Kingdom) used Illumina (San Diego, CA, USA) instruments and microarray technology to determine differentially methylated sites in whole blood and in immunomagnetically separated leucocytes (CD4+ and CD8+ lymphocytes and CD14+ monocytes) from 240 newly-diagnosed IBD cases and 190 controls.

The investigators reported that they had identified differentially methylated positions (DMPs) and regions (DMRs) in whole-blood DNA samples from 240 newly diagnosed IBD cases (121 Crohn's disease and 119 ulcerative colitis) and 191 controls. More...
Technical validation and detailed characterization of DMRs was performed in a small cohort of six cases (three Crohn's disease and three ulcerative colitis) and three controls using whole-genome bisulphite sequencing. Independent validation of methylation results was performed using bisulphite pyrosequencing in a further cohort of 240 patients with established IBD and 98 controls.

Senior author Dr. Jack Satsangi, professor of gastroenterology at the University of Edinburgh, said, "Our findings bring fresh insights to the underlying causes of inflammatory bowel diseases, which could eventually lead to new treatments. Characterizing epigenetic signatures in the DNA of patients could help us to devise better tests for diagnosing these diseases, so that patients can be given the best possible care."

The study was published in the November 25, 2016, online edition of the journal Nature Communications.

Related Links:
University of Edinburgh
Illumina

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Urine samples can indicate lupus nephritis without the need for repeat and painful renal biopsies (Photo courtesy of Shutterstock)

Urine Test Could Replace Painful Kidney Biopsies for Lupus Patients

Lupus is an autoimmune disorder that causes the immune system to attack the body’s own tissues and organs. Among the five million people living with lupus globally, nearly half develop lupus nephritis,... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.